Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 JSH guideline for tumors of hematopoietic and lymphoid tissues-lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN).

× No keyword cloud information.

6 in total

Review 1. Chronic myelogenous leukemia presenting with central nervous system infiltration, successfully treated with central nervous system-directed chemotherapy followed by allogeneic stem cell transplantation.

Authors: Akira Chiba; Takashi Toya; Hideaki Mizuno; Junji Tokushige; Fumihiko Nakamura; Kumi Nakazaki; Mineo Kurokawa
Journal: Int J Hematol Date: 2018-08-04 Impact factor: 2.490

2. Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan.

Authors: Ayako Kamiunten; Kotaro Shide; Takuro Kameda; Masaaki Sekine; Yoko Kubuki; Masafumi Ito; Takanori Toyama; Noriaki Kawano; Kousuke Marutsuka; Kouichi Maeda; Masanori Takeuchi; Hiroshi Kawano; Seiichi Sato; Junzo Ishizaki; Keiichi Akizuki; Yuki Tahira; Haruko Shimoda; Tomonori Hidaka; Kiyoshi Yamashita; Hitoshi Matsuoka; Kazuya Shimoda
Journal: Int J Hematol Date: 2018-02-27 Impact factor: 2.490

3. Budget impact analysis of treatment-free remission in nilotinib-treated Japanese chronic myeloid leukemia patients.

Authors: Kiyotaka Yamazaki; Naohito Inagaki; Daniel Moldaver; Ricardo Viana; Shinya Kimura
Journal: Cancer Sci Date: 2020-05-23 Impact factor: 6.716

4. Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naïve essential thrombocythemia patients in a real-world setting.

Authors: Tomoki Ito; Yoshinori Hashimoto; Yasuhiro Tanaka; Aya Nakaya; Shinya Fujita; Atsushi Satake; Takahisa Nakanishi; Akiko Konishi; Masaaki Hotta; Hideaki Yoshimura; Kazuyoshi Ishii; Akiko Hashimoto; Toshinori Kondo; Hiromi Omura; Isaku Shinzato; Takayuki Tanaka; Shosaku Nomura
Journal: Eur J Haematol Date: 2019-06-17 Impact factor: 2.997

Review 5. The Myeloproliferative Neoplasm Landscape: A Patient's Eye View.

Authors: Cheryl Petruk; Jonathan Mathias
Journal: Adv Ther Date: 2020-04-23 Impact factor: 3.845

6. Combined Effects of 2-Methoxyestradiol (Hypoxia-Inducible Factor 1α Inhibitor) and Dasatinib (A Second-Generation Tyrosine Kinase Inhibitor) on Chronic Myelocytic Leukemia Cells.

Authors: Yuexian Zhang; Heng Chen; Yunfeng Shen; Xin Zhou
Journal: J Immunol Res Date: 2022-04-28 Impact factor: 4.493

6 in total